Therapeutic targeting of immunometabolism in Alzheimer's disease reveals a critical reliance on Hexokinase 2 dosage on microglial activation and disease progression.
Saved in:
| Title: | Therapeutic targeting of immunometabolism in Alzheimer's disease reveals a critical reliance on Hexokinase 2 dosage on microglial activation and disease progression. |
|---|---|
| Authors: | Codocedo JF; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA., Mera-Reina C; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA., Lin PB; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA., Puntambekar SS; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA., Casali BT; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA., Jury N; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA., Martinez P; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA., Lasagna-Reeves CA; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA., Landreth GE; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA. |
| Source: | BioRxiv : the preprint server for biology [bioRxiv] 2023 Nov 15. Date of Electronic Publication: 2023 Nov 15. |
| Publication Type: | Preprint; Journal Article |
| Journal Info: | Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
